| Product Name | MF | CAS | Details |
|---|
| Antho-RFamide | C22H32N8O5 | 107535-01-3 | Details |
| Antho-RPamide III · HCl | C42H68N12O9 | 763074-36-8 | Details |
| Anxiety Peptide | C81H138N24O29 | 95237-86-8 | Details |
| α Bag Cell Peptide (1-9) | C53H83N15O12 | 87549-52-8 | Details |
| β-Bag Cell Peptide (Aplysia californica) | C33H53N13O6 | 109024-47-7 | Details |
| Bradykinin-Like Neuropeptide (Aplysia californica) | C53H98N24O14S | 165174-60-7 | Details |
| Buccalin | C45H72N12O15S | 116786-35-7 | Details |
| Cerebellin | C69H113N23O23 | 94071-26-8 | Details |
| (Des-Ser1)-Cerebellin | C66H108N22O21 | 94245-80-4 | Details |
| Cortistatin-17 (human) | C96H139N27O24S3 | 189450-19-9 | Details |
| Delta-Sleep Inducing Peptide | C35H48N10O15 | 62568-57-4 | Details |
| (Asn5)-Delta-Sleep Inducing Peptide | C35H49N11O14 | 80064-67-1 | Details |
| (β-Asp5)-Delta-Sleep Inducing Peptide | C35H48N10O15 | 82602-88-8 | Details |
| Eledoisin | C54H85N13O15S | 69-25-0 | Details |
| Head activator (7-11) | C32H54N6O6 | 103404-59-7 | Details |
| Head activator | C54H84N12O14 | 79943-68-3 | Details |
| (D-Tyr11)-Neurotensin | C78H121N21O20 | 64088-62-6 | Details |
| Neurotensin (1-6) | C35H52N8O12 | 87620-09-5 | Details |
| Neurotensin (1-8) | C46H71N13O14 | 80887-44-1 | Details |
| Neurotensin (1-11) | C66H99N19O18 | 74032-89-6 | Details |
| Neurotensin (8-13) | C38H64N12O8 | 60482-95-3 | Details |
| Acetyl-Neurotensin (8-13) | C40H66N12O9 | 74853-69-3 | Details |
| (Dab9)-Neurotensin (8-13) | C36H60N10O8 | 166824-25-5 | Details |
| (Lys8-psi(CH2NH)Lys9)-Neurotensin (8-13) | C38H66N8O7 | 139026-66-7 | Details |
| H-Tyr-Gln-Ser-Leu-Arg-Trp-NH2 | C40H58N12O9 | 328074-18-6 | Details |
| Kinetensin | C56H85N17O11 | 103131-69-7 | Details |
| (Trp11)-Neurotensin | C80H122N22O19 | 75644-95-0 | Details |
| (D-Trp11)-Neurotensin | C80H122N22O19 | 100929-52-0 | Details |
| Secretoneurin (mouse, rat) | C28H33NO7 | 149146-12-3 | Details |
| Neurotensin | C78H121N21O20 | 55508-42-4 | Details |
| He-LWamide II | C35H53N9O6 | 198995-08-3 | Details |
| Hemokinin 1 (human) | C54H84N14O14S | 491851-53-7 | Details |
| Hemokinin 1 (mouse, rat) | C61H100N22O15S | 208041-90-1 | Details |
| Hippocampal Cholinergic Neurostimulating Peptide | C53H79N13O17 | 140158-49-2 | Details |
| Leech Osmoregulatory Factor | C50H67N9O14 | 175413-77-1 | Details |
| LymnaDFamide-1 | C68H96N18O22 | 148596-98-9 | Details |
| Metamorphosin A | C34H47N9O8 | 157622-03-2 | Details |
| Neuropeptide FF | C54H76N14O10 | 99566-27-5 | Details |
| (D-Tyr1,N-Me-Phe3)-Neuropeptide FF | C55H78N14O11 | 145274-93-7 | Details |
| Neuropeptide K (human, porcine, rat) | C8H11NO4 | 96827-05-3 | Details |
| Neuropeptide S (human) | C93H155N31O28S | 412938-67-1 | Details |
| Neuropeptide S (rat) | C95H160N34O27 | 412938-75-1 | Details |
| Neuropeptide W-23 (human) | C119H183N35O28S | 383415-79-0 | Details |
| Neuropeptide W-23 (rat) | C119H183N35O29S | 383415-89-2 | Details |
| Neuropeptide W-30 (human) | C165H249N49O37S | 383415-80-3 | Details |
| Nociceptin (1-13) amide | C61H100N22O15 | 178064-02-3 | Details |
| (Phe1-(R)-Gly2)-Nociceptin (1-13) amide | C61H102N22O14 | 213130-17-7 | Details |
| Peptide Lv (rat) | 1872441-58-1 | Details |
| H-Phe-Gly-Gly-Phe-OH | C22H26N4O5 | 40204-87-3 | Details |
| RF9 | C26H38N6O3 | 876310-60-0 | Details |
| Scyliorhinin I | C59H87N13O13S | 103425-21-4 | Details |
| (Des-Bromo)-Neuropeptide B (1-23) (human) | C107H162N30O30 | 434897-64-0 | Details |
| Neuropeptide γ | C99H158N34O29S | 114882-65-4 | Details |
| Neuropeptide GE | C81H125N23O34 | 134748-04-2 | Details |
| Neuropeptide S (1-10) (human) | C42H68N14O14S | 904910-39-0 | Details |
| Biotinyl-Neuropeptide W-23 (human) | C129H197N37O30S2 | 1815618-09-7 | Details |
| Neuropeptide W-30 (rat) | C165H249N49O38S | 383415-90-5 | Details |
| Nociceptin | C79H129N27O22 | 170713-75-4 | Details |
| Prokineticin 2 Isoform 2 (human) | 423206-00-2 | Details |
| (Leu31,Pro34)-Neuropeptide Y (13-36) (human, rat) | C134H206N40O35S | 302798-54-5 | Details |
| Neuropeptide Y (13-36) (porcine) | C135H209N41O36 | 113662-54-7 | Details |
| Pancreatic Polypeptide (1-17)-(Ala31,Aib32)-Neuropeptide Y (18-36) (human) | 313988-70-4 | Details |
| Neuropeptide Y (18-36) | C112H174N36O27 | 114495-97-5 | Details |
| Neuropeptide Y (22-36) | C85H139N29O21 | 119019-65-7 | Details |
| Acetyl-(Leu28·31)-Neuropeptide Y (24-36) | C81H131N27O19 | 155709-24-3 | Details |
| Tyr-Lys-Gly-(Cyclo(Glu26-Lys29),Pro34)-Neuropeptide Y (25-36) | C91H145N27O20 | 185032-24-0 | Details |
| (D-Tyr27·36,D-Thr32)-Neuropeptide Y (27-36) | C61H99N19O15 | 163887-48-7 | Details |
| ((Cys31,Nva34)-Neuropeptide Y (27-36))2 | C116H186N36O28S2 | 172997-92-1 | Details |
| (Pro30,Tyr32,Leu34)-Neuropeptide Y (28-36) | C57H91N17O12 | 161650-01-7 | Details |
| (His32,Leu34)-Neuropeptide Y (32-36) | C33H54N14O6 | 168916-68-5 | Details |
| (Gly1,Ser3·22,Gln4·34,Thr6,Arg19,Tyr21, Ala23·31,Aib32)-Pancreatic Polypeptide (human) | C183H281N57O54S2 | 313988-89-5 | Details |
| PYX-1 | C70H105Cl2N19O16 | 140842-17-7 | Details |
| Ac-Asp-Glu-OH | C11H16N2O8 | 3106-85-2 | Details |
| Ac-Asp(Glu-OH)-OH | C11H16N2O8 | 4910-46-7 | Details |
| Anthopleurin-A | C215H326N62O67S6 | 60880-63-9 | Details |
| (Lys9,Trp11,Glu12)-Neurotensin (8-13) (Cyclic Analog) | C39H59N11O8 | 160662-16-8 | Details |
| Neurotensin (9-13) | C32H52N8O7 | 60482-96-4 | Details |
| Boc-(Lys9)-Neurotensin (9-13)-methyl ester hydrochloride salt | C38H62N6O9 | 89545-20-0 | Details |
| Brain Injury Derived Neurotrophic Peptide | C62H102N18O18 | 148330-12-5 | Details |
| Saposin C (15-32) (rat) | C89H155N21O29 | 175922-65-3 | Details |
| H-Abu-Gly-OH | C6H12N2O3 | 16305-80-9 | Details |
| H-Glu(Abu-OH)-OH | C9H16N2O5 | 16869-42-4 | Details |
| H-Glu(Gly-Gly-OH)-OH | C9H15N3O6 | 13640-39-6 | Details |
| Ophthalmic Acid | C11H19N3O6 | 495-27-2 | Details |
| Acetalin-2 | C44H66N14O7S2 | 152274-66-3 | Details |
| BAM-12P (7-12) | C29H52N12O9 | 321940-50-5 | Details |
| BAM-12P | C62H97N21O16S | 75513-71-2 | Details |
| BAM-22P | C130H184N38O31S2 | 76622-26-9 | Details |
| BAM-22P (8-22) | C91H127N25O23S | 412961-36-5 | Details |
| BAM-3200 | C147H207N41O34S2 | 78355-50-7 | Details |
| α-Casein (90-95) | C38H57N9O9 | 83471-50-5 | Details |
| α-Casein (90-96) | C43H64N10O12 | 83471-49-2 | Details |
| β-Casomorphin (bovine) | C41H55N7O9 | 72122-62-4 | Details |
| β-Casomorphin (human) | C44H61N7O11 | 102029-74-3 | Details |
| β-Casomorphin (1-2) | C14H18N2O4 | 51871-47-7 | Details |
| β-Casomorphin (1-3) amide | C23H28N4O4 | 80705-23-3 | Details |
| β-Casomorphin (1-3) | C23H27N3O5 | 72122-59-9 | Details |
| β-Casomorphin (1-4) (bovine) | C28H34N4O6 | 74171-19-0 | Details |
| β-Casomorphin (1-4) amide (bovine) | C28H35N5O5 | 74135-04-9 | Details |
| β-Casomorphin (1-5) (bovine) | C30H37N5O7 | 72122-63-5 | Details |
| Product Total： Product Page： | ||||
| 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 | ||||